I am an undergraduate student at UC Berkeley pursuing a double major in Business Administration (Haas School of Business) and Economics, with a strong academic foundation and a 3.98 GPA. As a Regents’ and Chancellor’s Scholar, I have a deep interest in financial markets, particularly in uncovering undervalued equities through rigorous fundamental and valuation analysis. My focus is primarily on healthcare, technology, and insurance sectors—industries where I believe investor mispricing and narrative bias frequently create alpha opportunities. I have hands-on experience in trading, portfolio construction, and financial modeling, and I regularly write deep-dive equity research articles to test theses and engage with other investors. My investing style blends growth-at-a-reasonable-price (GARP) principles with a contrarian lens, often targeting companies temporarily misunderstood by the market. I also write on Seeking Alpha to develop and share high-quality investment research that goes beyond surface-level commentary. I aim to deliver insightful, data-backed perspectives—grounded in long-term fundamentals and macro awareness. My goal is to grow as an investor while building a network of thoughtful, detail-oriented readers and contributors.
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
#UnitedHealth #Group #StockUndervaluation #Healthcare #Titan #UNH